Study Stopped
Difficulty in recruiting patients
Treatment Strategy for Low-grade Gliomas
1 other identifier
interventional
500
1 country
1
Brief Summary
Although the prognosis of patients with low-grade glioma (LGG) is generally good, recurrence seems unavoidable in some patients because of the infiltrative growth of the tumors. How to treat LGGs is still under controversy. The role of radiation therapy and chemotherapy in the treatment of LGG need to be further investigated. The purpose of this study is the following:
- 1.to investigate the role of early radiation therapy in MRI-determined total resected LGGs;
- 2.to compare the efficacy of early radiation therapy and that of initial chemotherapy in the LGGs without total resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 8, 2009
CompletedFirst Posted
Study publicly available on registry
May 12, 2009
CompletedAugust 5, 2014
May 1, 2009
May 8, 2009
August 4, 2014
Conditions
Outcome Measures
Primary Outcomes (2)
Efficacy of early radiation therapy in MRI-determined total resected LGGs: evaluated as 5-year progression-free survival.
10 years
Efficacy of early radiation therapy vs. initial chemotherapy with temozolomide in LGGs without total resection: evaluated as 5-year progression-free survival.
10 years
Study Arms (4)
Total resection with early radiation
EXPERIMENTALTotal resected LGGs treated with early radiation
Total resection without radiation
NO INTERVENTIONTotal resected LGGs treated without radiation
Residual LGGs with radiation
EXPERIMENTALResidual LGGs treated with early radiation
Residual LGGs with chemo
EXPERIMENTALResidual LGGS treated with temozolomide
Interventions
Eligibility Criteria
You may qualify if:
- Histologically confirmed newly diagnosed low-grade gliomas
- Karnofsky performance status of 60 or more
You may not qualify if:
- Previous history of radiation therapy or chemotherapy for gliomas
- Pregnant or breast feeding
- Diagnosis of another malignancy may exclude subject from study
- Evidence or history of bleeding diathesis
- Evidence or history of hypersensitivity to temozolomide
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zhongping Chen, M.D., Ph.D.
Sun Yat-sen University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 8, 2009
First Posted
May 12, 2009
Study Start
December 1, 2007
Last Updated
August 5, 2014
Record last verified: 2009-05